XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Sales:    
Net sales $ 138,878 $ 133,911
Costs and expenses:    
Research and development 10,369 11,070
Sales, marketing and support 23,229 25,554
General and administrative 24,656 28,794
Total costs and expenses 144,532 153,506
Loss from operations (5,654) (19,595)
Interest income 1,507 886
Interest expense 3 56
Other income, net 772 7,111
Loss from continuing operations before income tax expense (3,378) (11,654)
Income tax expense (benefit) from continuing operations 546 (108)
Net loss from continuing operations (3,924) (11,546)
Income from discontinued operations, net of tax 28,025 1,783
Net Income (loss) $ 24,101 $ (9,763)
Net loss from continuing operations per common share    
Basic (in dollars per share) $ (0.21) $ (0.63)
Diluted (in dollars per share) (0.21) (0.63)
Net income from discontinued operations per common share    
Basic (in dollars per share) 1.50 0.10
Diluted (in dollars per share) 1.50 0.10
Net income (loss) per common share    
Basic (in dollars per share) 1.29 (0.54)
Diluted (in dollars per share) $ 1.29 $ (0.54)
Weighted average number of shares outstanding:    
Basic (in shares) 18,632 18,217
Diluted (in shares) 18,632 18,217
Product    
Sales:    
Net sales $ 26,970 $ 30,012
Costs and expenses:    
Cost of product and service sales 25,184 23,951
Service    
Sales:    
Net sales 111,908 103,899
Costs and expenses:    
Cost of product and service sales $ 61,094 $ 64,137